Skip to content
SlushFund

Agencies · awarding agency 075 · HHS

Department of Health and Human Services

Share of this agency’s prime contract dollars that it coded “not competed”, by fiscal year, from USAspending’s agency totals.

FY2024
9.2%

of contract dollars were not competed: $2.8B of $29.9B

USAspendingas of Oct 3
FY2025
11.5%

of contract dollars were not competed: $2.5B of $21.3B

USAspendingas of Oct 3
FY2026
11.6%

of contract dollars were not competed: $2.9B of $24.9B

USAspendingas of Oct 3
Source: USAspending.govCoverage: Agency contract totals FY2024–FY2026 · Contract awards FY2024–FY2026Updated: Methodology →

Contract dollars by fiscal year

All prime contract obligations of the agency, split by the agency's competition code. Every figure is from USAspending's agency totals.

Contract obligations, non-competed and competed, by fiscal year
Fiscal yearAll contract obligationsNot competedCompetedShare not competed
FY2024Oct 1 – Sep 30, 2024$29.9B$2.8B$27.1B9.2%
FY2025Oct 1 – Sep 30, 2025$21.3B$2.5B$18.8B11.5%
FY2026Oct 1 – Sep 30, 2026$24.9B$2.9B$22.0B11.6%

Source: USAspending.gov agency totals, prime contract types A–D, by contract-action date; fetched Oct 3, 2026. “Not competed” = extent-competed code not available for competition, not competed, not competed under simplified acquisition, or non-competitive delivery order. Orders placed under a competed contract keep its code, so they count as competed.

Largest non-competed awards in our records

A look at the biggest individual awards behind the share. These rows do not add up to the totals above.

Largest non-competed awards from Department of Health and Human Services, FY2024 (obligated to date)
Source
75A50124C00057ERVEBO PROCUREMENTMERCK SHARP & DOHME LLCSep 27, 2024FY2024Not competedOnly one source-other (FAR 6.302-1 other)$156,033,983USAspending
75A50324C00006ANTHIM (OBILTOXAXIMAB)ELUSYS THERAPEUTICS INCApr 30, 2024FY2024Not competedMobilization, essential r&d (FAR 6.302-3)$124,523,123USAspending
75N99024F00038Order under IDV 47PA0420D0064C107469 ELECTRICAL SUBSTATION UPGRADE PHASE 1APOTOMAC ELECTRIC POWER COSep 26, 2024FY2024Not available for competitionUtilities (FAR 6.302-1(b)(3))$122,189,393USAspending
75N90024C00007PHARMACEUTICALS AND RELATED SUPPLIES FOR THE NIH CLINICAL CENTER (CC), PHARMACY DEPARTMENT.DLA TROOP SUPPORTNov 14, 2023FY2024Not competedOnly one source-other (FAR 6.302-1 other)$82,620,000USAspending
75D30124C19450DOSE RECONSTRUCTIONOAK RIDGE ASSOCIATED UNIVERSITIES, INCORPORATEDAug 9, 2024FY2024Not competedOnly one source-other (FAR 6.302-1 other)$57,750,000USAspending
75FCMC24F0196Order under IDV 75FCMC23D0004POLICY AND OPERATIONAL SERVICES IN SUPPORT OF THE CONSUMER SUPPORT GROUP (CSG) FOR THE CENTER FOR CONSUMER INFORMATION AND INSURANCE OVERSIGHT (CCIIO)THE MITRE CORPORATIONSep 23, 2024FY2024Not competedMobilization, essential r&d (FAR 6.302-3)$45,440,097USAspending
75FCMC24F0200Order under IDV 75FCMC23D0004STRATEGIC SERVICES IN SUPPORT OF FACILITATING LEADERSHIP IN ADVANCED MEASUREMENT EXCELLENCE (FLAME)THE MITRE CORPORATIONSep 16, 2024FY2024Not competedMobilization, essential r&d (FAR 6.302-3)$35,210,195USAspending
75ACF124C00023CASE COORDINATION BRIDGEGENERAL DYNAMICS INFORMATION TECHNOLOGY, INC.Sep 30, 2024FY2024Not competedOnly one source-other (FAR 6.302-1 other)$35,175,033USAspending
75FCMC24F0100Order under IDV 75FCMC23D0004TITLE IS SOLUTIONS TO SUPPORT INNOVATION IN PURSUIT OF AFFORDABLE AND BETTER HEALTH CARETHE MITRE CORPORATIONJun 26, 2024FY2024Not competedMobilization, essential r&d (FAR 6.302-3)$33,645,144USAspending
75A50424C00006OVER THE COUNTER (OTC) COVID-19 TESTS - GAO CORRECTIVE ACTIONATLANTIC TRADING LLCSep 5, 2024FY2024Not competedMobilization, essential r&d (FAR 6.302-3)$26,510,400USAspending
75D30124C19403NATIONAL PROGRAM OF CANCER REGISTRIES CANCER SURVEILLANCE INFORMATICS SYSTEMGC&E FEDERAL, LLCJul 17, 2024FY2024Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))$26,321,728USAspending
75H70124C00052WESTERN OREGON SERVICE UNIT (WOSU) SCHOOL BASED HEALTH CENTER (SBHC) DESIGN-BUILDTSS-JCC LLCSep 27, 2024FY2024Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))$22,640,641USAspending
75D30124C19250IQVIA PHARMACY DATAIQVIA GOVERNMENT SOLUTIONS INCSep 24, 2024FY2024Not competedOnly one source-other (FAR 6.302-1 other)$20,883,149USAspending
75N95024F00003Order under IDV 75N95023D00027THIS CONTRACT WILL ESTABLISH A DATA PROGRAM MANAGEMENT ORGANIZATION (DPMO)PALANTIR TECHNOLOGIES INC.Jun 5, 2024FY2024Not competedFollow-on contract (FAR 6.302-1(a)(2)(ii/iii))$20,372,013USAspending
75FCMC24F0180Order under IDV 75FCMC23D0004CCIIO EXCHANGE STRATEGIC, OPERATIONS AND ACQUISITION SUPPORTTHE MITRE CORPORATIONSep 9, 2024FY2024Not competedMobilization, essential r&d (FAR 6.302-3)$18,522,091USAspending
75D30124C18393MEETING MANAGEMENT TECHNOLOGY SERVICES SUPPORTCHENEGA ENTERPRISE SYSTEMS & SOLUTIONS, LLCDec 29, 2023FY2024Not competed under SAPAuthorized by statute (FAR 6.302-5(a)(2)(i))$18,253,341USAspending
75H70624F03002Order under IDV 75H70623D00023TASK ORDER ISSUED AGAINST 75H70623D00023 TO TRIBAL HEALTH, LLC TO PROVIDE EMERGENCY ROOM DEPARTMENT SERVICES FOR THE ROSEBUD AND PINE RIDGE IHS HOSPITALS IN SOUTH DAKOTA. PERIOD OF PERFORMANCE: JANUARY 1, 2024 THROUGH MARCH 31, 2024.TRIBAL HEALTH, LLCDec 22, 2023FY2024Not competedUrgency (FAR 6.302-2)$16,515,192USAspending
75FCMC24F0218Order under IDV 75FCMC23D0004TECHNOLOGY AGILE ENTERPRISE MARKET INSIGHT & MONITORING (TAEMIM)THE MITRE CORPORATIONSep 25, 2024FY2024Not competedMobilization, essential r&d (FAR 6.302-3)$15,723,565USAspending
75D30124F00001Order under IDV 75D30124D20201IMMUNIZATION INFOMATION SERVICES IDIQSTCHEALTH LLCSep 26, 2024FY2024Not competedOnly one source-other (FAR 6.302-1 other)$14,188,268USAspending
75D30124C20203LABORATORY DIRECTOR UNIVERSITY TRAINING DESIGN AND IMPLEMENTATIONSUMMOME NATIVE VENTURES LLCSep 20, 2024FY2024Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))$13,298,293USAspending
75D30124C20063LABORATORY QUALITY MGMT SUPPORTTANAQ MANAGEMENT SERVICES LLCSep 11, 2024FY2024Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))$13,128,072USAspending
75D30124C19958ESSENCETHE JOHNS HOPKINS UNIVERSITY APPLIED PHYSICS LABORATORY LLCSep 24, 2024FY2024Not competedOnly one source-other (FAR 6.302-1 other)$13,105,714USAspending
75F40124C00138FDA SAFETY INTAKE PROCESSING SYSTEMS (SIPS) PROGRAMCHICKASAW SERVICE SOLUTIONS, LLCSep 30, 2024FY2024Not competedFollow-on contract (FAR 6.302-1(a)(2)(ii/iii))$13,071,297USAspending
75F40124F80370Order under IDV 75FCMC23D0004FOOD AND DRUG ADMINISTRATION (FDA) CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) BIOLOGIC EFFECTIVENESS AND SAFETY (BEST) INNOVATIVE METHODS (IM) PROGRAM COR: BRIAN HIVELY BRIAN.HIVELY@FDA.HHS.GOV 3-WAY COST (REQUIRES CO/CS APPROVAL)THE MITRE CORPORATIONSep 27, 2024FY2024Not competedMobilization, essential r&d (FAR 6.302-3)$11,688,771USAspending
75H71324C00002SIHB - URBAN INDIAN HEALTH CARE SERVICES - SEATTLE, WASHINGTONSEATTLE INDIAN HEALTH BOARDSep 27, 2024FY2024Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))$11,487,085USAspending

Largest non-competed awards from Department of Health and Human Services, FY2024 (obligated to date)

  • 75A50124C00057ERVEBO PROCUREMENT
    Signed
    Sep 27, 2024FY2024
    Competition
    Not competedOnly one source-other (FAR 6.302-1 other)
    Obligated to date
    $156,033,983
  • 75A50324C00006ANTHIM (OBILTOXAXIMAB)
    Signed
    Apr 30, 2024FY2024
    Competition
    Not competedMobilization, essential r&d (FAR 6.302-3)
    Obligated to date
    $124,523,123
  • 75N99024F00038Order under IDV 47PA0420D0064C107469 ELECTRICAL SUBSTATION UPGRADE PHASE 1A
    Signed
    Sep 26, 2024FY2024
    Competition
    Not available for competitionUtilities (FAR 6.302-1(b)(3))
    Obligated to date
    $122,189,393
  • 75N90024C00007PHARMACEUTICALS AND RELATED SUPPLIES FOR THE NIH CLINICAL CENTER (CC), PHARMACY DEPARTMENT.
    Signed
    Nov 14, 2023FY2024
    Competition
    Not competedOnly one source-other (FAR 6.302-1 other)
    Obligated to date
    $82,620,000
  • 75D30124C19450DOSE RECONSTRUCTION
    Signed
    Aug 9, 2024FY2024
    Competition
    Not competedOnly one source-other (FAR 6.302-1 other)
    Obligated to date
    $57,750,000
  • 75FCMC24F0196Order under IDV 75FCMC23D0004POLICY AND OPERATIONAL SERVICES IN SUPPORT OF THE CONSUMER SUPPORT GROUP (CSG) FOR THE CENTER FOR CONSUMER INFORMATION AND INSURANCE OVERSIGHT (CCIIO)
    Signed
    Sep 23, 2024FY2024
    Competition
    Not competedMobilization, essential r&d (FAR 6.302-3)
    Obligated to date
    $45,440,097
  • 75FCMC24F0200Order under IDV 75FCMC23D0004STRATEGIC SERVICES IN SUPPORT OF FACILITATING LEADERSHIP IN ADVANCED MEASUREMENT EXCELLENCE (FLAME)
    Signed
    Sep 16, 2024FY2024
    Competition
    Not competedMobilization, essential r&d (FAR 6.302-3)
    Obligated to date
    $35,210,195
  • 75ACF124C00023CASE COORDINATION BRIDGE
    Signed
    Sep 30, 2024FY2024
    Competition
    Not competedOnly one source-other (FAR 6.302-1 other)
    Obligated to date
    $35,175,033
  • 75FCMC24F0100Order under IDV 75FCMC23D0004TITLE IS SOLUTIONS TO SUPPORT INNOVATION IN PURSUIT OF AFFORDABLE AND BETTER HEALTH CARE
    Signed
    Jun 26, 2024FY2024
    Competition
    Not competedMobilization, essential r&d (FAR 6.302-3)
    Obligated to date
    $33,645,144
  • 75A50424C00006OVER THE COUNTER (OTC) COVID-19 TESTS - GAO CORRECTIVE ACTION
    Signed
    Sep 5, 2024FY2024
    Competition
    Not competedMobilization, essential r&d (FAR 6.302-3)
    Obligated to date
    $26,510,400
  • 75D30124C19403NATIONAL PROGRAM OF CANCER REGISTRIES CANCER SURVEILLANCE INFORMATICS SYSTEM
    Signed
    Jul 17, 2024FY2024
    Competition
    Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))
    Obligated to date
    $26,321,728
  • 75H70124C00052WESTERN OREGON SERVICE UNIT (WOSU) SCHOOL BASED HEALTH CENTER (SBHC) DESIGN-BUILD
    Signed
    Sep 27, 2024FY2024
    Competition
    Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))
    Obligated to date
    $22,640,641
  • 75D30124C19250IQVIA PHARMACY DATA
    Signed
    Sep 24, 2024FY2024
    Competition
    Not competedOnly one source-other (FAR 6.302-1 other)
    Obligated to date
    $20,883,149
  • 75N95024F00003Order under IDV 75N95023D00027THIS CONTRACT WILL ESTABLISH A DATA PROGRAM MANAGEMENT ORGANIZATION (DPMO)
    Signed
    Jun 5, 2024FY2024
    Competition
    Not competedFollow-on contract (FAR 6.302-1(a)(2)(ii/iii))
    Obligated to date
    $20,372,013
  • 75FCMC24F0180Order under IDV 75FCMC23D0004CCIIO EXCHANGE STRATEGIC, OPERATIONS AND ACQUISITION SUPPORT
    Signed
    Sep 9, 2024FY2024
    Competition
    Not competedMobilization, essential r&d (FAR 6.302-3)
    Obligated to date
    $18,522,091
  • 75D30124C18393MEETING MANAGEMENT TECHNOLOGY SERVICES SUPPORT
    Signed
    Dec 29, 2023FY2024
    Competition
    Not competed under SAPAuthorized by statute (FAR 6.302-5(a)(2)(i))
    Obligated to date
    $18,253,341
  • 75H70624F03002Order under IDV 75H70623D00023TASK ORDER ISSUED AGAINST 75H70623D00023 TO TRIBAL HEALTH, LLC TO PROVIDE EMERGENCY ROOM DEPARTMENT SERVICES FOR THE ROSEBUD AND PINE RIDGE IHS HOSPITALS IN SOUTH DAKOTA. PERIOD OF PERFORMANCE: JANUARY 1, 2024 THROUGH MARCH 31, 2024.
    Signed
    Dec 22, 2023FY2024
    Competition
    Not competedUrgency (FAR 6.302-2)
    Obligated to date
    $16,515,192
  • 75FCMC24F0218Order under IDV 75FCMC23D0004TECHNOLOGY AGILE ENTERPRISE MARKET INSIGHT & MONITORING (TAEMIM)
    Signed
    Sep 25, 2024FY2024
    Competition
    Not competedMobilization, essential r&d (FAR 6.302-3)
    Obligated to date
    $15,723,565
  • 75D30124F00001Order under IDV 75D30124D20201IMMUNIZATION INFOMATION SERVICES IDIQ
    Signed
    Sep 26, 2024FY2024
    Competition
    Not competedOnly one source-other (FAR 6.302-1 other)
    Obligated to date
    $14,188,268
  • 75D30124C20203LABORATORY DIRECTOR UNIVERSITY TRAINING DESIGN AND IMPLEMENTATION
    Signed
    Sep 20, 2024FY2024
    Competition
    Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))
    Obligated to date
    $13,298,293
  • 75D30124C20063LABORATORY QUALITY MGMT SUPPORT
    Signed
    Sep 11, 2024FY2024
    Competition
    Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))
    Obligated to date
    $13,128,072
  • 75D30124C19958ESSENCE
    Signed
    Sep 24, 2024FY2024
    Competition
    Not competedOnly one source-other (FAR 6.302-1 other)
    Obligated to date
    $13,105,714
  • 75F40124C00138FDA SAFETY INTAKE PROCESSING SYSTEMS (SIPS) PROGRAM
    Signed
    Sep 30, 2024FY2024
    Competition
    Not competedFollow-on contract (FAR 6.302-1(a)(2)(ii/iii))
    Obligated to date
    $13,071,297
  • 75F40124F80370Order under IDV 75FCMC23D0004FOOD AND DRUG ADMINISTRATION (FDA) CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) BIOLOGIC EFFECTIVENESS AND SAFETY (BEST) INNOVATIVE METHODS (IM) PROGRAM COR: BRIAN HIVELY BRIAN.HIVELY@FDA.HHS.GOV 3-WAY COST (REQUIRES CO/CS APPROVAL)
    Signed
    Sep 27, 2024FY2024
    Competition
    Not competedMobilization, essential r&d (FAR 6.302-3)
    Obligated to date
    $11,688,771
  • 75H71324C00002SIHB - URBAN INDIAN HEALTH CARE SERVICES - SEATTLE, WASHINGTON
    Signed
    Sep 27, 2024FY2024
    Competition
    Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))
    Obligated to date
    $11,487,085
The 25 largest non-competed awards of $1M+ signed in FY2024 (rule r5-v1). “Obligated to date” is the total committed on the award so far, including later modifications, not spending in a fiscal year. Source: USAspending.gov award records.